EGFR Gene Selective Sequencing of Exons 18-21 NGS Genetic DNA Test
Introduction
The EGFR Gene Selective Sequencing of Exons 18-21 NGS Genetic DNA Test is a cutting-edge diagnostic tool that utilizes Next Generation Sequencing (NGS) technology to analyze specific regions of the EGFR gene. This test is crucial for patients with cancer, particularly lung cancer, as it helps to identify mutations that may influence treatment decisions. Understanding the genetic makeup of tumors can lead to more personalized and effective treatment options.
What the Test Measures
This test specifically measures mutations in exons 18 to 21 of the EGFR gene. These mutations are often associated with non-small cell lung cancer (NSCLC) and can significantly impact the effectiveness of targeted therapies.
Who Should Consider This Test?
Patients with the following conditions should consider undergoing the EGFR Gene Selective Sequencing Test:
- Symptoms of lung cancer, such as persistent cough, chest pain, or unexplained weight loss.
- Individuals with a family history of lung cancer or other related cancers.
- Patients who have been diagnosed with non-small cell lung cancer and are seeking targeted therapy options.
Benefits of Taking the Test
- Personalized Treatment: Identifying specific mutations allows oncologists to tailor treatment plans to the individual’s genetic profile.
- Improved Outcomes: Targeted therapies based on genetic testing can lead to better treatment responses and outcomes.
- Informed Decision-Making: Patients can make informed decisions about their treatment options based on their genetic information.
Understanding Your Results
Once the test is completed, results will be provided detailing any mutations found in the EGFR gene. It is important to discuss these results with your oncologist, who can explain the implications for your treatment plan and any further steps that may be necessary.
Test Pricing
| Price Type | Amount (NGN) |
|---|---|
| Discount Price | 400000 NGN |
| Regular Price | 560000 NGN |
Book the Test Today!
To schedule your EGFR Gene Selective Sequencing of Exons 18-21 NGS Genetic DNA Test, please call or WhatsApp us at +2348077798758. Take a step towards understanding your health and making informed decisions about your treatment options.
Additional Information
- Turnaround Time: 3 to 4 Weeks
- Sample Type: Blood or Extracted DNA or One drop Blood on FTA Card
- Pre-test Instructions: Clinical history of the patient and a genetic counseling session to draw a pedigree chart of family members affected.
- Specialty: Oncologist
- Department: Genetics
- Method: NGS Technology
- Disease Type: Cancer
